Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter

NACompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

January 31, 2014

Conditions
Atrial Flutter
Interventions
DEVICE

Blazer® Open-Irrigated Ablation Catheter

Blazer® Open-Irrigated Ablation Catheter

DEVICE

Control Catheter

Open-irrigated radiofrequency ablation catheters that have received FDA market approval for the treatment of type 1 atrial flutter

Trial Locations (26)

14642

Strong Memorial Hospital of the University of Rochester, Rochester

20010

Washington Hospital Center, Washington D.C.

23507

Sentara Norfolk General Hospital, Norfolk

27401

Moses H. Cone Memorial Hospital, Greensboro

29403

Medical University of South Carolina, Charleston

30308

Emory University Hospital, Atlanta

30912

Georgia Health Sciences University, Augusta

32308

Tallahassee Memorial Hospital, Tallahassee

34667

West Coast Arrhythmia Center, Hudson

35294

University of Alabama at Birmingham, Birmingham

40503

Central Baptist Hospital, Lexington

43210

Ohio State University Medical Center, Columbus

43214

Ohio Health Research Institute, Columbus

43606

ProMedica Toledo Hospital, Toledo

44195

Cleveland Clinic Foundation, Cleveland

48202

Henry Ford Hospital, Detroit

66160

University of Kansas Hospital, Kansas City

68526

Nebraska Heart Institute, Lincoln

77030

Hall Garcia Cardiology, Houston

78705

Texas Cardiac Arrhythmia Research, Austin

80907

Colorado Springs Cardiologist, P.C., Colorado Springs

92835

St. Jude Medical Center, Fullerton

95819

Regional Cardiology Associates, Sacramento

98133

Swedish Medical Center, Seattle

02115

Brigham and Women's Hospital, Boston

02135

Caritas St. Elizabeth's Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY